These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12065572)

  • 21. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
    Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
    J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparison of results obtained in single-institution and multicenter trials.
    Bacci G; Mercuri M; Longhi A; Setola E; Gozzi E; Forni C
    Chir Organi Mov; 2004; 89(4):283-92. PubMed ID: 16048049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant form.
    Avella M; Bacci G; McDonald DJ; Di Scioscio M; Picci P; Campanacci M
    Chemioterapia; 1988 Apr; 7(2):133-7. PubMed ID: 3165057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy for osteosarcoma of the extremities: the Rizzoli Institute experience.
    Bacci G; Avella M; Picci P; Ruggieri P; Biagini R; Ferruzzi A; Casadei R; Caldora P; Campanacci M
    Chir Organi Mov; 1990; 75(1 Suppl):57-9. PubMed ID: 2249559
    [No Abstract]   [Full Text] [Related]  

  • 25. Current treatment of high grade osteosarcoma of the extremity: review.
    Bacci G; Lari S
    J Chemother; 2001 Jun; 13(3):235-43. PubMed ID: 11450880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
    Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
    J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoadjuvant treatment in osteosarcomas].
    Kalifa C; Brugières L; Le Deley MC
    Bull Cancer; 2006 Nov; 93(11):1115-20. PubMed ID: 17145581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol.
    Serra M; Pasello M; Manara MC; Scotlandi K; Ferrari S; Bertoni F; Mercuri M; Alvegard TA; Picci P; Bacci G; Smeland S
    Int J Oncol; 2006 Dec; 29(6):1459-68. PubMed ID: 17088985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
    Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
    Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
    [No Abstract]   [Full Text] [Related]  

  • 30. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
    Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Present status of the chemotherapy of malignant bone tumors].
    Yamawaki S
    Nihon Seikeigeka Gakkai Zasshi; 1992 Jan; 66(1):126-36. PubMed ID: 1548438
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adjuvant chemotherapy for osteosarcoma in Japan--past, present and future].
    Furuse K; Maeyama I; Morimoto K; Orito T
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1746-56. PubMed ID: 6591859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
    Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nonmetastatic osteosarcoma of the limbs treated with neoadjuvant chemotherapy: correlation of tumor volume evaluated by CT and prognosis].
    Moio A; Ferrari S; Iantorno D; Monti C; Bacci G
    Minerva Med; 1994 Dec; 85(12):615-23. PubMed ID: 7854554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].
    Werner M; Fuchs N; Salzer-Kuntschik M; Winkler K; Delling G
    Pathologe; 1996 Jan; 17(1):35-43. PubMed ID: 8685094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.
    Iwamoto Y; Tanaka K
    Jpn J Clin Oncol; 2012 Jun; 42(6):467-70. PubMed ID: 22628611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    Prilozi; 2008 Dec; 29(2):309-23. PubMed ID: 19259055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
    Pratt CB; Epelman S; Jaffe N
    Cancer Treat Rep; 1987 Apr; 71(4):421-3. PubMed ID: 2435408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.